Research and analysis

Vaginal oestrogen for prevention of primary urinary tract infections

This rapid review aimed to identify and summarise the effectiveness of vaginal oestrogen in women who are experiencing peri menopause, menopause or post menopause to prevent primary urinary tract infections.

• From: UK Health Security Agency
• Published: 12 December 2024

Documents

The effectiveness of vaginal oestrogen in women who are experiencing peri menopause, menopause or post menopause to prevent primary urinary tract infections: a rapid review.

Ref: GOV-17673

PDF, 446 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This rapid review aimed to identify and summarise the available evidence on the effectiveness of vaginal oestrogen in women who are experiencing peri menopause, menopause or post menopause to prevent primary urinary tract infections.

This rapid review searched for research published up to 26 February 2024.

No studies matching the inclusion criteria were found, so no evidence could be presented.

Published 12 December 2024